---
title: 'Dual-use research and research using enhanced pathogens in high-income countries:
  whose business?'
date: '2024-06-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38869288/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240613182215&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'U.S. regulation of dual-use research of concern and of research with
  enhanced pathogens of pandemic potential may alter soon. Much has been written on
  the best form for that regulation to take. Less was written on a procedural question:
  whose voices should shape that regulation? This commentary addresses the latter,
  the procedural question, regarding the appropriate parties to the deliberations
  and decisions on this matter. It proposes to U.S. virologists that it would be in
  the interests ...'
disable_comments: true
---
U.S. regulation of dual-use research of concern and of research with enhanced pathogens of pandemic potential may alter soon. Much has been written on the best form for that regulation to take. Less was written on a procedural question: whose voices should shape that regulation? This commentary addresses the latter, the procedural question, regarding the appropriate parties to the deliberations and decisions on this matter. It proposes to U.S. virologists that it would be in the interests ...